Geron Corporation(GERN): For the most recent quarter end, Geron Corporation reported Annual Earnings of $-0.02. Based on the filings, last years Annual Earnings was, $0. For the most recent quarter end, GERN reported a surprise Earnings per Share of 66.67% . The consensus estimate for current quarter is $-0.06 and for the current fiscal year, the estimate is $-0.19. For the Next fiscal year, the estimate is $-0.11 based on the consensus.
Geron Corporation has received $-0.06 as the consensus Earnings Estimate for the Quarter ending on Dec 2016 ,According to the estimate provided by 3 Financial Advisor in the Stock Trading Firms. Among 3 Analysts, Bottom line EPS Estimate for the current quarter is $-0.07 while the top line estimate is $-0.05 , a key information to consider for Day Trading and investing in stocks. The EPS growth rate is projected at -13.33%. Geron Corporation reported better than expected with a surprise EPS of 66.67% or $0.04 during its most recent quarterly earnings. The Actual EPS was $-0.02 compared to the Estimated EPS of $-0.06.
Geron Corporation Last issued its quarterly earnings results on Nov 3, 2016. The company reported $-0.02 EPS for the quarter, beating the analyst consensus estimate by $ 0.04. Analyst had a consensus of $-0.06. The company had revenue of $5.10 million for the quarter, compared to analysts expectations of $.22 million. The companys revenue was down -85.6 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.17 EPS.
Company has reported several Insider transactions to the SEC, on Jun 1, 2015, Olivia Kyusuk Bloom (EVP, Chief Financial Officer) sold 2,380 shares at 3.84 per share price.On Jun 1, 2015, Melissa Kelly Behrs (EVP BD and Port&Alliance Mgmt) sold 2,380 shares at 3.84 per share price.On Mar 19, 2015, Thomas Hofstaetter (director) sold 70,000 shares at 4.10 per share price.
Geron Corporation (NASDAQ:GERN) witnessed a decline in the market cap on Wednesday as its shares dropped 2.73% or 0.06 points. After the session commenced at $2.19, the stock reached the higher end at $2.25 while it hit a low of $2.13. With the volume soaring to 862,273 shares, the last trade was called at $2.14. The company has a 52-week high of $3.35. The company has a market cap of $341 million and there are 159,145,090 shares in outstanding. The 52-week low of the share price is $1.81.
Geron Corporation is a scientific research company that is developing techniques for the health services industry. Their research is currently divided in three different areas. First, they are looking into telomeres and telomerase and their roles in cellular aging and cancer. Second, they are looking pluripotent stem cells as a potential source for the manufacturing of replacement cells and tissues. Lastly, the company is researching nuclear transfer as a potential mechanism for generating genetically matched cells and tissues.